FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact

被引：0
|
作者：
Marianne Vogsen
Jeanette Dupont Jensen
Ivar Yannick Christensen
Oke Gerke
Anne Marie Bak Jylling
Lisbet Brønsro Larsen
Poul-Erik Braad
Katrine Lydolph Søe
Camilla Bille
Marianne Ewertz
Malene Grubbe Hildebrandt
机构：
[1] Odense University Hospital,Department of Oncology
[2] Odense University Hospital,Department of Nuclear Medicine
[3] University of Southern Denmark,Department of Clinical Research
[4] Odense University Hospital,Odense Patient Data Explorative Network
[5] Odense University Hospital,Centre for Personalized Response Monitoring in Oncology (PREMIO)
[6] Odense University Hospital,Department of Radiology
[7] Odense University Hospital,Department of Pathology
[8] Odense University Hospital,Department of Breast Surgery
[9] Odense University Hospital,Department of Plastic Surgery
[10] Odense University Hospital,Centre for Innovative Medical Technology
[11] Odense University Hospital,Department of Oncology and Department of Nuclear Medicine
来源：
Breast Cancer Research and Treatment | 2021年 / 185卷
关键词：
Breast cancer; FDG-PET/CT; Stage migration; Clinical impact; Incidental findings;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：145 / 153
页数：8
相关论文
共 50 条
  • [31] Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
    Baun, Christina
    Falch, Kirsten
    Gerke, Oke
    Hansen, Jeanette
    Tram Nguyen
    Alavi, Abass
    Hoilund-Carlsen, Poul-Flemming
    Hildebrandt, Malene G.
    BMC MEDICAL IMAGING, 2018, 18
  • [32] Present and future role of FDG-PET/CT imaging in the management of breast cancer
    Kazuhiro Kitajima
    Yasuo Miyoshi
    Japanese Journal of Radiology, 2016, 34 : 167 - 180
  • [33] Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
    Christina Baun
    Kirsten Falch
    Oke Gerke
    Jeanette Hansen
    Tram Nguyen
    Abass Alavi
    Poul-Flemming Høilund-Carlsen
    Malene G. Hildebrandt
    BMC Medical Imaging, 18
  • [34] FDG-PET Dynamic Contrast-Enhanced CT in the Management of Breast Cancer
    Das, Chandan J.
    Al-Mullah, Abeer
    Kumar, Rakesh
    PET CLINICS, 2009, 4 (03) : 255 - 263
  • [35] Present and future role of FDG-PET/CT imaging in the management of breast cancer
    Kitajima, Kazuhiro
    Miyoshi, Yasuo
    JAPANESE JOURNAL OF RADIOLOGY, 2016, 34 (03) : 167 - 180
  • [36] CLINICAL IMPACT OF FDG-PET IN PATIENTS WITH SUSPECTED RECURRENT OVARIAN CANCER
    Cuenca Cuenca, J. I.
    Borrego Dorado, I.
    Vazquez Albertino, R.
    Gomez Camarero, P.
    Sanz Viedma, S.
    Fernandez Lopez, R.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2008, 27 (06): : 411 - 417
  • [37] Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer
    Kumar, Rakesh
    Chauhan, Anil
    Zhuang, Hongming
    Chandra, Prem
    Schnall, Mitchell
    Alavi, Abass
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 98 (03) : 267 - 274
  • [38] PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?
    Ulaner, Gary A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (02) : 254 - 265
  • [39] Correlation of primary tumor metabolic parameters with clinical, histopathological and molecular characteristics in breast cancer patients at pre-operative staging FDG-PET/CT study
    AbdElaal, Asmaa A.
    Zaher, Ahmed M.
    Abdelgawad, Marwa, I
    Mekkawy, Mohamed A.
    Eloteify, Lamiaa M.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01)
  • [40] The Effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients being Planned Neoadjuvant Treatment
    Simsek, Eda Tanrikulu
    Coban, Ezgi
    Atag, Elif
    Gungor, Serkan
    Aker, Fugen
    Sari, Murat
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 181 - 185
12345